Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-660-9 | CAS number: 839-90-7
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: according to information in OECD SIDS (2002)
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 002
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Tris(2-hydroxyethyl)-1,3,5-triazinetrione
- EC Number:
- 212-660-9
- EC Name:
- Tris(2-hydroxyethyl)-1,3,5-triazinetrione
- Cas Number:
- 839-90-7
- Molecular formula:
- C9H15N3O6
- IUPAC Name:
- tris(2-hydroxyethyl)-1,3,5-triazinane-2,4,6-trione
- Details on test material:
- - Identity: Tris(2-hydroxyethyl) isocyanurate (CAS: 839-90-7)
- Source: Nissan Chemical Industries Ltd.; Lot No. 00915-1
- Purity: 99.0 %
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Age of the animals at study initiation: 5 weeks old
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- for injection
- Doses:
- 0, 500, 1,000, 2,000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- Control animals comprised a concurrent vehicle control group
- Statistics:
- Not applicable, because of no fatality.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- None
- Clinical signs:
- other: No treatment related clinical sign observed.
- Gross pathology:
- No treatment-related abnormalities.
- Other findings:
- There was no treatment-related adverse effect.
Applicant's summary and conclusion
- Interpretation of results:
- other: LD50 > 2000 mg/kg body weight
- Conclusions:
- There were no treatment related abnormalities. LD50 is greater than 2,000 mg/kg for both sexes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
